Showing results (511-520 of 903) with videos related to

Sort By:
Pageof 91
Journal of Hepatology|August 27, 2013
Is there sufficient evidence to recommend antiviral therapy in hepatitis C?Adriaan J van der Meer, Heiner Wedemeyer, Jordan J Feld, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 3, 2008
Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantationNazanin Hooman, Kinan Rifai, Johannes Hadem, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2008
Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failureJohannes Hadem, Penelope Stiefel, Matthias J Bahr, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 19, 2014
Autoimmune hepatitis in the Alaska Native population: autoantibody profile and HLA associationsElizabeth D Ferucci, Tammy L Choromanski, Kathy J Hurlburt, et al.
Nature Reviews. Disease Primers|March 14, 2025
Primary sclerosing cholangitisMichael P Manns, Annika Bergquist, Tom H Karlsen, et al.
Frontiers in Immunology|May 8, 2026
Particularly strong immune response to influenza vaccination in patients with decompensated liver cirrhosis linked to systemic inflammationJanyn Heisig, Valerie Ohlendorf, Nhan Nguyen, et al.
JHEP Reports : Innovation in Hepatology|March 4, 2024
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatmentAndré Gömer, Katja Dinkelborg, Mara Klöhn, et al.
Hepatology (Baltimore, Md.)|July 9, 2004
Long-term follow-up after successful interferon therapy of acute hepatitis CJohannes Wiegand, Elmar Jäckel, Markus Cornberg, et al.
Journal of Hepatology|July 22, 2022
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paperThomas Marjot, Christiane S Eberhardt, Tobias Boettler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2023
Quality-of-life scores improve after 96 weeks of PEG-IFNa-2a treatment of hepatitis D: An analysis of the HIDIT-II trialKatja Dinkelborg, Julia Kahlhöfer, Petra Dörge, et al.
Pageof 91